Clifton-Bligh RJ - Search Results

1

Wnt pathway inhibitors are strongly down-regulated in pituitary tumors.

Elston MS, Gill AJ, Conaglen JV, Clarkson A, Shaw JM, Law AJ, Cook RJ, Little NS, Clifton-Bligh RJ, Robinson BG, McDonald KL. Elston MS, et al. Endocrinology. 2008 Mar;149(3):1235-42. doi: 10.1210/en.2007-0542. Epub 2007 Dec 13. Endocrinology. 2008. PMID: 18079202

2

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

Cheung L, Messina M, Gill A, Clarkson A, Learoyd D, Delbridge L, Wentworth J, Philips J, Clifton-Bligh R, Robinson BG. Cheung L, et al. J Clin Endocrinol Metab. 2003 Jan;88(1):354-7. doi: 10.1210/jc.2002-021020. J Clin Endocrinol Metab. 2003. PMID: 12519876

3

PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth.

Au AY, McBride C, Wilhelm KG Jr, Koenig RJ, Speller B, Cheung L, Messina M, Wentworth J, Tasevski V, Learoyd D, Robinson BG, Clifton-Bligh RJ. Au AY, et al. Endocrinology. 2006 Jan;147(1):367-76. doi: 10.1210/en.2005-0147. Epub 2005 Sep 22. Endocrinology. 2006. PMID: 16179407

4

The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

Foukakis T, Au AY, Wallin G, Geli J, Forsberg L, Clifton-Bligh R, Robinson BG, Lui WO, Zedenius J, Larsson C. Foukakis T, et al. J Clin Endocrinol Metab. 2006 Mar;91(3):1143-9. doi: 10.1210/jc.2005-1372. Epub 2005 Dec 13. J Clin Endocrinol Metab. 2006. PMID: 16352687

5

Elevated serum FGF23 concentrations in plasma cell dyscrasias.

Stewart I, Roddie C, Gill A, Clarkson A, Mirams M, Coyle L, Ward C, Clifton-Bligh P, Robinson BG, Mason RS, Clifton-Bligh RJ. Stewart I, et al. Bone. 2006 Aug;39(2):369-76. doi: 10.1016/j.bone.2006.01.163. Epub 2006 Apr 27. Bone. 2006. PMID: 16644301

6

A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.

Elston MS, Stewart IJ, Clifton-Bligh R, Conaglen JV. Elston MS, et al. Bone. 2007 Jan;40(1):236-41. doi: 10.1016/j.bone.2006.07.027. Epub 2006 Sep 18. Bone. 2007. PMID: 16982223

7

PTH mutation with primary hyperparathyroidism and undetectable intact PTH.

Au AY, McDonald K, Gill A, Sywak M, Diamond T, Conigrave AD, Clifton-Bligh RJ. Au AY, et al. N Engl J Med. 2008 Sep 11;359(11):1184-6. doi: 10.1056/NEJMc0802570. N Engl J Med. 2008. PMID: 18784115 No abstract available.

8

Headache of a diagnosis: frontotemporal pain and inflammation associated with osteolysis.

Tacon LJ, Parkinson JF, Hudson BJ, Brewer JM, Little NS, Clifton-Bligh RJ. Tacon LJ, et al. Med J Aust. 2008 Nov 17;189(10):591-2. doi: 10.5694/j.1326-5377.2008.tb02190.x. Med J Aust. 2008. PMID: 19012561

9

Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.

McCormack AI, McDonald KL, Gill AJ, Clark SJ, Burt MG, Campbell KA, Braund WJ, Little NS, Cook RJ, Grossman AB, Robinson BG, Clifton-Bligh RJ. McCormack AI, et al. Clin Endocrinol (Oxf). 2009 Aug;71(2):226-33. doi: 10.1111/j.1365-2265.2008.03487.x. Epub 2008 Dec 3. Clin Endocrinol (Oxf). 2009. PMID: 19067722

10

Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas.

Elston MS, Gill AJ, Conaglen JV, Clarkson A, Cook RJ, Little NS, Robinson BG, Clifton-Bligh RJ, McDonald KL. Elston MS, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1436-42. doi: 10.1210/jc.2008-2075. Epub 2009 Jan 21. J Clin Endocrinol Metab. 2009. PMID: 19158195

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters